Biodimension competitors & alternatives

Biotechnology

iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.

FluicellFLUI · Health CareSweden

65% matchPublic

Health Care

Fluicell develops precision-engineered biological tissues and single-cell bioprinting technologies for regenerative medicine and drug screening. Using its proprietary platforms, including Nexocyte and Biopixlar, the company creates transplantable tissues to target diseases such as type 1 diabetes and provides advanced tools and screening models for pharmaceutical and academic partners.

Biotechnology

Bit Bio is a UK biotechnology company that develops technologies for precisely programming human cells, including its opti-ox platform for producing consistent, scalable cell types. It serves biomedical researchers, drug developers, and regenerative-medicine and cell-therapy developers with engineered human cells and related tools.

Obatala Sciences, Inc.HealthcareUnited States

63% matchPrivate

Healthcare

Obatala Sciences, Inc. is a biotechnology company that provides organ-on-a-chip solutions for research, with its office located in New Orleans, Louisiana.

サイフューズ4892 · BiotechTokyo, Japan

62% matchPublic

Biotech

Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.

Biotechnology

Pandorum Technologies is a deep-tech biotechnology company based in Bangalore, India, pioneering tunable tissue regenerative medicine and building blocks of life.

RenaissTheraBiotechnologyIndia

68% match

Biotechnology

RenaissThera is a privately held biotechnology company headquartered in Bengaluru, India, dedicated to developing affordable, AI-powered small-molecule targeted therapies.

immunitoAIBiotechnologyIndia

67% match

Biotechnology

immunitoAI is a TechBio research company founded in 2020 that develops AI-driven platforms to unlock the potential of antibody therapeutics. Headquartered in Bengaluru, Karnataka, India, the company employs a team of 11 to 50 professionals.

Biotechnology

Frontier Bio develops engineered human tissues and vascular grafts to address cardiovascular disease and eliminate the need for organ donors and animal testing. The company provides tissue-engineered blood vessels for vascular grafts and commercializes human-based tissue models and services for preclinical testing.

Aspect BiosystemsBiotech

66% matchAI 30/100Green 0/100

Biotech

Aspect Biosystems develops bioengineered cellular medicines and implantable tissue therapeutics using a proprietary bioprinting platform that integrates AI, computational design, and advanced biomaterials. The company serves the biotechnology and pharmaceutical industries by creating treatments to replace, repair, or supplement biological functions for metabolic and endocrine diseases.

VivoSim Labs, Inc.VIVS · HealthtechSan Diego, United States

65% matchPublic

Healthtech

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Vivodyne, Inc.Biotech

65% matchPrivate

Biotech

Vivodyne is a biotechnology company headquartered in Philadelphia, Pennsylvania, with presence in the San Francisco Bay Area, that uses autonomous labs to grow realistic human tissues and generate human data at scale for pharmaceutical research.